Position in A
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,252,597
+$85,392,837 QoQ
Shares Held
814,971
+385.1% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#55
of 1,112 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $929,620,379 across 10 Diagnostics & Research names. A ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
401,082 | $211,145,608 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
376,071 | $188,546,956 | |
| 3 | A |
Agilent Technologies, Inc.
This page
|
814,971 | $108,252,597 | |
| 4 | ILMN |
Illumina, Inc.
|
581,730 | $102,285,585 | |
| 5 | GH |
Guardant Health, Inc.
|
647,818 | $97,192,134 | |
| 6 | RDNT |
RadNet, Inc.
|
1,171,721 | $72,260,034 | |
| 7 | DHR |
Danaher Corp /De/
|
310,000 | $59,048,800 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
235,000 | $53,295,650 |
All Filings in A
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,252,597 | 814,971 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $22,859,760 | 168,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $82,351,670 | 641,618 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $20,799,262 | 176,250 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $25,988,159 | 222,159 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||